Replies to post #14067 on Relief Therapeutics Holding AG (RLFTF)

[Gls3ms]

I’ve googled it and it looks like 3 weeks roughly. I’d like to think this one would get expedited since it seriously is a life and death issue.

[Andy2018]

DMC interim data review is important. DMC might HALT the trial and recommend FDA accelerated approval since they can’t keep patients on control arm it’s ethical to bring treatment to all patients if treatment arm is promising over control arm in 102 Patients. $RLFTF

[TraderInvictus]

3 weeks is the average for peer review. I would like to think they would be on the lower end of the spectrum and get it done in 2 weeks, which would put us at late next week for review confirmation.